These tools will no longer be maintained as of December 31, 2024. Archived website can be found here. PubMed4Hh GitHub repository can be found here. Contact NLM Customer Service if you have questions.


BIOMARKERS

Molecular Biopsy of Human Tumors

- a resource for Precision Medicine *

223 related articles for article (PubMed ID: 23488559)

  • 1. Neuroprotection after cerebral ischemia.
    Namura S; Ooboshi H; Liu J; Yenari MA
    Ann N Y Acad Sci; 2013 Mar; 1278():25-32. PubMed ID: 23488559
    [TBL] [Abstract][Full Text] [Related]  

  • 2. Neuroprotection in the Treatment of Acute Ischemic Stroke.
    Patel RAG; McMullen PW
    Prog Cardiovasc Dis; 2017; 59(6):542-548. PubMed ID: 28465001
    [TBL] [Abstract][Full Text] [Related]  

  • 3. Cerebral ischemia and stroke--highlights of the 5th International Symposium on Neuroprotection and Neurorepair in Magdeburg, Germany, May 17-20, 2008.
    Reiser G; Reymann K
    Restor Neurol Neurosci; 2009; 27(2):79-81. PubMed ID: 19289860
    [No Abstract]   [Full Text] [Related]  

  • 4. [Animal models of cerebral ischemia--testing therapeutic strategies in vivo].
    Erdô F; Hossmann KA
    Ideggyogy Sz; 2007 Sep; 60(9-10):356-69. PubMed ID: 17987730
    [TBL] [Abstract][Full Text] [Related]  

  • 5. Editorial: Targeting Cerebral Vascular Injury for Intervention.
    Zhang JH
    Curr Drug Deliv; 2017 Sep; 14(6):742-743. PubMed ID: 29461176
    [No Abstract]   [Full Text] [Related]  

  • 6. The role of the complement cascade in ischemia/reperfusion injury: implications for neuroprotection.
    D'Ambrosio AL; Pinsky DJ; Connolly ES
    Mol Med; 2001 Jun; 7(6):367-82. PubMed ID: 11474130
    [TBL] [Abstract][Full Text] [Related]  

  • 7. Heat shock protein 27 as a neuroprotective biomarker and a suitable target for stem cell therapy and pharmacotherapy in ischemic stroke.
    Behdarvandy M; Karimian M; Atlasi MA; Azami Tameh A
    Cell Biol Int; 2020 Feb; 44(2):356-367. PubMed ID: 31502740
    [TBL] [Abstract][Full Text] [Related]  

  • 8. The application and neuroprotective mechanisms of cerebral ischemic post-conditioning: A review.
    Li Z; Chen H; Lv J; Zhao R
    Brain Res Bull; 2017 May; 131():39-46. PubMed ID: 28284901
    [TBL] [Abstract][Full Text] [Related]  

  • 9. Recent Progress in Therapeutic Strategies for Ischemic Stroke.
    Yamashita T; Abe K
    Cell Transplant; 2016; 25(5):893-8. PubMed ID: 26786838
    [TBL] [Abstract][Full Text] [Related]  

  • 10. Targeting the brain: neuroprotection and neurorestoration in ischemic stroke.
    Saver JL
    Pharmacotherapy; 2010 Jul; 30(7 Pt 2):62S-9S. PubMed ID: 20575624
    [TBL] [Abstract][Full Text] [Related]  

  • 11. Gene expression in cerebral ischemia: a new approach for neuroprotection.
    Millán M; Arenillas J
    Cerebrovasc Dis; 2006; 21 Suppl 2():30-7. PubMed ID: 16651812
    [TBL] [Abstract][Full Text] [Related]  

  • 12. New targets of neuroprotection in ischemic stroke.
    Bacigaluppi M; Hermann DM
    ScientificWorldJournal; 2008 Jul; 8():698-712. PubMed ID: 18661057
    [TBL] [Abstract][Full Text] [Related]  

  • 13. Improving outcome after stroke: overcoming the translational roadblock.
    Endres M; Engelhardt B; Koistinaho J; Lindvall O; Meairs S; Mohr JP; Planas A; Rothwell N; Schwaninger M; Schwab ME; Vivien D; Wieloch T; Dirnagl U
    Cerebrovasc Dis; 2008; 25(3):268-78. PubMed ID: 18292653
    [TBL] [Abstract][Full Text] [Related]  

  • 14. Cerebral protection, brain repair, plasticity and cell therapy in ischemic stroke.
    Gutiérrez M; Merino JJ; Alonso de Leciñana M; Díez-Tejedor E
    Cerebrovasc Dis; 2009; 27 Suppl 1():177-86. PubMed ID: 19342849
    [TBL] [Abstract][Full Text] [Related]  

  • 15. Targeting vascular inflammation in ischemic stroke: Recent developments on novel immunomodulatory approaches.
    Shekhar S; Cunningham MW; Pabbidi MR; Wang S; Booz GW; Fan F
    Eur J Pharmacol; 2018 Aug; 833():531-544. PubMed ID: 29935175
    [TBL] [Abstract][Full Text] [Related]  

  • 16. Adoptive regulatory T-cell therapy protects against cerebral ischemia.
    Li P; Gan Y; Sun BL; Zhang F; Lu B; Gao Y; Liang W; Thomson AW; Chen J; Hu X
    Ann Neurol; 2013 Sep; 74(3):458-71. PubMed ID: 23674483
    [TBL] [Abstract][Full Text] [Related]  

  • 17. EndothelinA receptor antagonist BSF-208075 causes immune modulation and neuroprotection after stroke in gerbils.
    Hauck EF; Hoffmann JF; Heimann A; Kempski O
    Brain Res; 2007 Jul; 1157():138-45. PubMed ID: 17506996
    [TBL] [Abstract][Full Text] [Related]  

  • 18. Cerebral ischemia, mechanisms and therapeutic approaches--current status.
    Kumar K
    Curr Opin Investig Drugs; 2006 Jul; 7(7):595-9. PubMed ID: 16869110
    [No Abstract]   [Full Text] [Related]  

  • 19. Neuroprotective effects of intravenous transplantation of bone marrow mononuclear cells from 5-fluorouracil pre-treated rats on ischemic stroke.
    Li Y; Mao WW; Zhang CG; Wan L; Jing CH; Hua XM; Li ST; Cheng J
    Behav Brain Res; 2016 Mar; 301():287-92. PubMed ID: 26219989
    [TBL] [Abstract][Full Text] [Related]  

  • 20. Trial design and reporting standards for intra-arterial cerebral thrombolysis for acute ischemic stroke.
    Higashida RT; Furlan AJ; Roberts H; Tomsick T; Connors B; Barr J; Dillon W; Warach S; Broderick J; Tilley B; Sacks D; ;
    Stroke; 2003 Aug; 34(8):e109-37. PubMed ID: 12869717
    [TBL] [Abstract][Full Text] [Related]  

    [Next]    [New Search]
    of 12.